REZILIENT3: Phase 3 study of zipalertinib plus chemotherapy in previously untreated, advanced nonsquamous NSCLC patients with EGFR exon 20 insertions Meeting Abstract
| Authors: | Yu, H. A.; Besse, B.; Nishio, M.; Cheng, Y.; Wei, L.; Wacheck, V.; Heymach, J. V. |
| Abstract Title: | REZILIENT3: Phase 3 study of zipalertinib plus chemotherapy in previously untreated, advanced nonsquamous NSCLC patients with EGFR exon 20 insertions |
| Meeting Title: | 2023 North America Conference on Lung Cancer |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 19 |
| Issue: | 7 Suppl. |
| Meeting Dates: | 2023 Dec 1-3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-01-01 |
| Start Page: | e40 |
| Language: | English |
| ACCESSION: | WOS:001277064200084 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2024.05.318 |
| Notes: | Meeting Abstract: PP01.88 -- Source: Wos |
